Long-term survival after pancreaticoduodenectomy for duodenal papillary adenocarcinoma in a patient with acquired immunodeficiency syndrome: A case report and review of literature

Table 3 Cases of people with human immunodeficiency virus undergoing radical resection for gastrointestinal tumors

Ref.	Number of cases	PWH/AIDS	Gender	Age (years)	CD4+ (cells/μL)	Albumin (g/L)	Regular ART treatment	Diagnosis	Treatment	Complications	Follow-up time	Outcome
Sseruwag et al[24], 2023	1	PWH	Female	67	363.00	36.29	Yes	DA	RYGJ + JJ
Salameh et al[25], 2013	1	PWH	Male	39	255.00		No	DA	PGJ + chemotherapy		2 weeks	Survival
Wildi et al[26], 2001	1	PWH	Female	33	100.00		No	PAC	PPPD	No	5 months	Survival
Ramdial et al[27], 2011	1	AIDS	Male	30	168.00	22.00	Yes	PAC	PPD	No	8 months	Survival
Ghatak et al[28], 2013	1	PWH	Female	44	604.00		No	PAC	PD	Gastric emptying delay	3 months	Survival
Hathaway et al[29], 2023	1	PWH	Male	68			No	CC	PD	POPF + pleural effusion
Gandhi et al[30], 2017	1	PWH	Male	40				CC	PD + chemotherapy
Poizot-Martin et al[31], 2018	1	PWH	Male	52	600.00		No	PHC	PD + chemotherapy	No	4 months	Survival
Loots et al[32], 2008	1	PWH	Male	44	123.00	19.00	No	PHC	PD + chemotherapy	Sepsis at wound and drain site	< 3 months	Survival

PWH: People with human immunodeficiency virus; AIDS: Acquired immunodeficiency syndrome; ART: Antiretroviral therapy; DA: Duodenal adenocarcinoma; RYGJ: Roux-en-Y gastrojejunostomy; JJ: Jejunojejunostomy; PGJ: Palliative gastrojejunostomy; PPPD: Pylorus-preserving pancreaticoduodenectomy; PPD: Partial pancreaticoduodenectomy; PD: Pancreaticoduodenectomy; PAC: Periampullary cancer; CC: Cholangiocarcinoma; PHC: Pancreatic head cancer; POPF: Pancreatic fistula.